On March 17, 2025, ANI Pharmaceuticals, Inc. exercised its buyout option related to the Iluvien royalty, which resulted in a payment of approximately $17.3 million to SWK.

In March 2025, through two transactions SWK monetized its performing royalty portfolio for approximately $51.3 million and anticipates declaring a dividend on the closing of the larger transaction.

SWK boasts a Value Style Score of B and VGM Score of A, and holds a Zacks Rank #3 (Hold) rating. Shares of Stanley Black & Decker are trading at a forward earnings multiple of 15.7X, as well as a ...

In this article, we are going to take a look at where Stanley Black & Decker, Inc. (NYSE:SWK) stands against other blue chip stocks to invest in at 52-week lows. For the first time since 2023 ...

Stanley Black & Decker (SWK) was already facing multiple tariff threats as President Donald Trump slaps levies on imports from Mexico, Canada and China; now the European Union could be a problem ...

Stanley Black & Decker Stock Performance NYSE:SWK opened at $76.46 on Monday. The firm’s fifty day simple moving average is $85.03 and its 200 day simple moving average is $90.10. The company ...

Get Our Latest Analysis on Stanley Black & Decker Stanley Black & Decker Trading Down 1.6 % NYSE SWK opened at $76.46 on Monday. Stanley Black & Decker, Inc. has a 12 month low of $76.25 and a 12 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

**NM signifies a non meaningful value. A dash signifies the data is not available.